Latest Research And Development News

Page 17 of 115
Volt Resources has secured US$5.4 million in fully government-funded support for its US graphite refinery and customer application centre. The award is positive for project funding, but the company’s ASX securities remain suspended as it works with the exchange to satisfy reinstatement requirements.
Victor Sage
Victor Sage
15 Sept 2026
Lithium Universe has secured selection for a proposed four-year Industry PhD project with Macquarie University and CSIRO to develop microwave-assisted recycling of end-of-life solar panels. The collaboration could strengthen the company’s technology pathway, but its grant, agreement and commercial outcomes remain unconfirmed.
Victor Sage
Victor Sage
15 Sept 2026
Simble Solutions’ NanoSensor has detected UV-A, UV-B, UV-C and visible wavelengths in initial laboratory testing, moving the platform into formal benchmarking. The result is an encouraging technical step, but commercial progress still depends on performance data, prototypes and customer validation.
Victor Sage
Victor Sage
14 Sept 2026
ABx Group and its ALCORE subsidiary have received nearly $600,000 in R&D tax offsets, while ALCORE has completed repayment of $2.61 million in unused government grant funds. The company is now awaiting a decision on a separate Industry Growth Program application worth up to $5 million.
Victor Sage
Victor Sage
14 Sept 2026
Great Dirt Resources has identified 24 priority manganese targets in New South Wales and confirmed rock-chip grades of up to 51.8% manganese. The exploration progress came alongside a $19.1 million FY2026 loss, largely caused by a non-cash share-based payments expense, while cash rose to $3.81 million.
Maxwell Dee
Maxwell Dee
10 Sept 2026
Greenvale Energy is expanding the final phase of Alpha Test Program 7 after Technix failed to produce a compliant C-170 paving-grade binder. SAMI Bitumen Technologies will now test conventional bitumen blending and additive-based formulations, with results expected from a six to eight-week laboratory program.
Victor Sage
Victor Sage
9 Sept 2026
Nexalis Therapeutics reports a 52% rise in half-year losses to $1.3 million amid funding facility cancellation and clinical trial suspensions, highlighting ongoing cash flow challenges.
Ada Torres
Ada Torres
1 Sept 2026
TALi Digital (ASX:TD1) is raising up to $3.3 million through a Security Purchase Plan and Placement to fund its acquisition of Datasphere Analytics and advance its AI-driven education platform.
Sophie Babbage
Sophie Babbage
1 Sept 2026
CurveBeam AI has secured over A$600,000 through its Share Purchase Plan, bolstering funds alongside a recent A$5 million placement. The capital will fuel the China launch and product development for its HiRise™ CT scanner.
Ada Torres
Ada Torres
1 Sept 2026
Cycliq Group Limited reported a 20.7% revenue decline to AUD 3.79 million for FY2026, but reduced its net loss by 83% to AUD 85,897, driven by disciplined cost control and strategic platform investments.
Sophie Babbage
Sophie Babbage
31 Aug 2026
Invex Therapeutics posted a $1.35 million net loss for FY2026, driven by expanded R&D efforts and a deepening collaboration with Tessara Therapeutics targeting neurological diseases including Alzheimer’s. The company renewed its orphan drug status in Europe and restructured its board during the year.
Ada Torres
Ada Torres
31 Aug 2026
Recce Pharmaceuticals narrowed its operating loss to AUD 15 million in FY26, progressing Phase 3 trials for its anti-infective RECCE 327 and securing key patents and commercial partnerships.
Ada Torres
Ada Torres
31 Aug 2026

Browse the archive

Full archive